DexCom develops, manufactures and distributes continuous glucose monitoring systems for diabetes management.
Read moreAnnual Revenue
$2.6B
Dexcom's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 11.1B. Over the last four quarters, Dexcom's revenue has grown by 5.7%. Specifically, in Q1 2022's revenue was $628.8M; in Q4 2021, it was $698.2M; in Q3 2021, it was $650.2M; in Q2 2021, Dexcom's revenue was $595.1M.